Guerbet
| Public (Euronext: GBT) | |
| Industry | Pharmaceutical |
| Founded | 1926 |
| Headquarters | Villepinte |
| Revenue | € 0.3 billion (2006) |
Number of employees | 1,250 (2006) |
| Slogan | Contrast for Life |
| Website | www.guerbet.com |
Guerbet is a research-centered pharmaceutical company based in France that is one of the major players in the contrast agents business.
The company's main products are:
- Xenetix (Iobitridol) - X-ray contrast agent marketed mainly in Europe;
- Oxilan (Ioxilan) - X-ray contrast agent marketed mainly in the United States;
- Dotarem (Gadoteric acid) - MRI contrast agent marketed mainly in Europe.
History
The company is named after the French chemist Marcel Guerbet (1861–1938), who produced Lipiodol in 1901 and his son André Guerbert, who founded the company in 1926. The X-ray contrast properties of Lipiodol were discovered in 1918.